Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
Anavo Therapeutics has raised $9.4M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Anavo Therapeutics's investors include Inkef, MRL Ventures Fund, Taiho Ventures, M Ventures, Bioqube Ventures.
Anavo Therapeutics is headquartered in Leiden, The Netherlands.
Anavo Therapeutics provides therapeutic potential of human phosphatase biology.
Anavo Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anavo Therapeutics — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/anavo-therapeutics. Accessed October 29, 2026.
VCBacked. (2023). Anavo Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/anavo-therapeutics
{{cite web |title=Anavo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/anavo-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated